Get the Stockscreener App
1.125
1.35%
0.015
Veraxa Biotech Ag stock is traded at $1.125, with a volume of 106.59K.
It is up +1.35% in the last 24 hours and down -25.99% over the past month.
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.
See More
Previous Close:
$1.11
Open:
$1.13
24h Volume:
106.59K
Relative Volume:
0.23
Market Cap:
$159.08M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
+3.21%
1M Performance:
-25.99%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$1.06
$1.15
1-Week Range:
$1.06
$1.4089
52-Week Range:
$1.04
$27.36
Veraxa Biotech Ag Stock (VRXA) Company Profile
Compare VRXA vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VRXA
Veraxa Biotech Ag
|
1.125 | 159.08M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
508.74 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.35 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.50 | 53.23B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.30 | 42.34B | 5.76B | 514.49M | 1.10B | 4.4813 |
Veraxa Biotech Ag Stock (VRXA) Latest News
VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy - GlobeNewswire Inc.
Veraxa Biotech AG (VRXA) Stock Price & News - Syfe
Form 4 Veraxa Biotech AG For: 29 September By Investing.com - Investing.com Nigeria
Form 4 Veraxa Biotech AG For: 29 September By Investing.com - Investing.com UK
LAWR Stock Price, Quote & News - Syfe
DSWL Stock Price, Quote & News - Syfe
Veraxa Biotech (VRXA) CFO named insider with no reported shares - Stock Titan
Veraxa Biotech AG Stock Price: VRXA Stock Chart, Market Cap & News Today - CoinGecko
VERAXA Biotech Appoints Dr. Christoph Erkel as CSO to Steer BiTAC® Toward Clinical Trials - citybuzz -
VERAXA Biotech Designates Raju Willener as CFO - Yahoo Finance
VERAXA Biotech (NASDAQ: VRXA) Appoints Raju Willener As Chief Financial Officer - Menafn
Veraxa Biotech AG (NASDAQ: VRXA) Revises Prospectus for Up to 120.3 Million Shares and Warrants - Kalkine Media
Veraxa Biotech AG (NASDAQ: VRXA) Names Raju Willener as CFO Following De-SPAC Completion - Kalkine Media
VERAXA Biotech (VRXA) Appoints Raju Willener as Chief Financial Officer - Yahoo Finance
Veraxa Biotech (VRXA) Insider Trading Activity 2026 - marketbeat.com
VERAXA Biotech (NASDAQ: VRXA) Appoints Raju Willener as Chief Financial Officer - TradingView
VRXA Rises As Veraxa Biotech AG Draws Trader Focus - timothysykes.com
Veraxa Biotech AG Company Profile & Introduction - Moomoo
VRXA Jumps As Traders Focus On Biotech Breakout Setup - timothysykes.com
VERAXA Biotech Appoints Veteran Finance Executive Raju Willener as CFO to Drive Capital Strategy and Oncology Pipeline Growth - citybuzz -
Veraxa Biotech AG (VRXA) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Veraxa Biotech names Raju Willener as chief financial officer By Investing.com - Investing.com Australia
Veraxa Biotech AG Announces Chief Financial Officer Changes - marketscreener.com
Veraxa Biotech stock rises after naming Raju Willener as CFO By Investing.com - Investing.com India
Veraxa Biotech stock rises after naming Raju Willener as CFO By Investing.com - Investing.com South Africa
Veraxa Biotech stock rises after naming Raju Willener as CFO By Investing.com - Investing.com Australia
Veraxa Biotech stock rises after naming Raju Willener as CFO By Investing.com - Investing.com Canada
Veraxa Biotech stock rises after naming Raju Willener as CFO By Investing.com - Investing.com Nigeria
Veraxa Biotech stock rises after naming Raju Willener as CFO - investing.com
Veraxa Biotech names Raju Willener as chief financial officer By Investing.com - Investing.com South Africa
Finance veteran behind CHF 30B portfolios joins Veraxa Biotech (VRXA) as CFO - Stock Titan
Veraxa Biotech names Raju Willener as chief financial officer By Investing.com - Investing.com Canada
Veraxa Biotech names Raju Willener as chief financial officer By Investing.com - Investing.com Nigeria
Veraxa Biotech names Raju Willener as chief financial officer - Investing.com
Veraxa Biotech names Raju Willener as chief financial officer By Investing.com - Investing.com India
VERAXA Biotech Appoints Raju Willener as Chief Financial Officer - kommunikasjon.ntb.no
Insider Buys Additional CHF75k In Veraxa Biotech Stock - simplywall.st
Veraxa Biotech AG Company Profile & Introduction - Moomoo
Veraxa Biotech (VRXA) 10K Form and Latest SEC Filings 2026 - MarketBeat
Veraxa Biotech (VRXA) Stock Price, News & Analysis - marketbeat.com
Veraxa Biotech (VRXA) Stock Chart and Price History 2026 - marketbeat.com
Veraxa Biotech (VRXA) director adds 50K shares in open-market buy - Stock Titan
Veraxa Biotech (VRXA) CEO now holds 5,000 ordinary shares - Stock Titan
VERAXA Biotech (NASDAQ: VRXA), Secarna Partnership Milestone Opens New Potential Market for Conjugation T - Benzinga
Early lab data advance Veraxa (Nasdaq: VRXA) autoimmune AOC - stocktitan.net
Veraxa and Secarna report positive early results from AOC study By Investing.com - Investing.com India
Veraxa Biotech AG - Via Ritzau
VERAXA Biotech and Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate (AOC) Alliance - The Manila Times
VERAXA Biotech AG: Valuation Ratios, Analysts' Forecasts - marketscreener.com
Veraxa Biotech (VRXA) interim CFO discloses zero share ownership - Stock Titan
Veraxa Biotech Ag Stock (VRXA) Financials Data
There is no financial data for Veraxa Biotech Ag (VRXA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Veraxa Biotech Ag Stock (VRXA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Antz Christoph Rudiger | Chief Executive Officer |
Aug 27 '26 |
Buy |
1.53 |
5,000 |
7,650 |
5,000 |
1.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):